I. Nishiyama

Safe and successful transition from oral selexipag to subcutaneous treprostinil in a patient with idiopathic pulmonary arterial hypertension treated with triple combination therapy

T. Murohara, T. Kondo, Y. Nakano, 2022, Journal of cardiology cases.

Right ventricular pressure overload related to residual thrombotic burden in patients 1 year after acute pulmonary embolism: From the Nagoya PE study.

S. Iwano, T. Murohara, T. Kondo, 2022, Thrombosis research.

Usefulness of a refined computed tomography imaging method to assess the prevalence of residual pulmonary thrombi in patients 1 year after acute pulmonary embolism: The Nagoya PE study

S. Iwano, T. Murohara, T. Kondo, 2022, Journal of thrombosis and haemostasis : JTH.

Inhaled iloprost induces long‐term beneficial hemodynamic changes in patients with pulmonary arterial hypertension receiving combination therapy

T. Murohara, Y. Nakano, K. Yasuda, 2022, Pulmonary circulation.

Prognostic Value of Delirium in Patients With Acute Heart Failure in the Intensive Care Unit.

S. Kazama, T. Murohara, T. Okumura, 2020, The Canadian journal of cardiology.

Clinical impact of heart rate change in patients with acute heart failure in the early phase

S. Kazama, T. Murohara, T. Okumura, 2021, ESC heart failure.

Detrimental Impact of Comorbid Mental Disorders in Chronic Thromboembolic Pulmonary Hypertension　― A Retrospective Observational Study ―

T. Murohara, Y. Nakano, K. Yasuda, 2024, Circulation reports.

Clinical value of the HATCH score for predicting adverse outcomes in patients with heart failure

T. Murohara, T. Asai, T. Okumura, 2022, Heart and Vessels.